Uterine fibroid, also known as myoma or leiomyoma, is a common benign tumor-like growth of the uterus. Fibroids are consisted of muscle and connective tissue.
Uterine fibroid causes symptoms of heavy prolonged menstrual bleeding, pelvic pain, frequent urination, and bloating. They can coexist with adenomyosis, a condition where normal endometrial tissue grows into the muscle of the uterus (see Adenomyosis).
Symptomatic fibroid tends to occurs in premenopausal women, women of child-bearing age. However, the effect can continues into the postmenopausal years in the form of urinary frequency, pelvic discomfort and bloating. Risk factors include family history, age, and race.
While clinically significant fibroid are commonly associated with African-American women, women from all ethnic background can develop and suffer from the symptoms of uterine fibroid.
Uterine Fibroid Embolization (UFE) offers an effective, safe alternative to hysterectomy. Unlike other treatment options for uterine fibroid, UFE is the most researched and well documented modality with proven favorable track record world wide.